Literature DB >> 34602025

Opportunistic free-living amoebal pathogens.

Mohammad Ridwane Mungroo1, Naveed Ahmed Khan1,2, Sutherland Maciver3, Ruqaiyyah Siddiqui4.   

Abstract

Pathogenic free-living amoebae affecting the central nervous system are known to cause granulomatous amoebic encephalitis (GAE) or primary amoebic meningoencephalitis (PAM). Although hosts with impaired immunity are generally at a higher risk of severe disease, amoebae such as Naegleria fowleri and Balamuthia mandrillaris can instigate disease in otherwise immunocompetent individuals, whereas Acanthamoeba species mostly infect immunocompromised people. Acanthamoeba also cause a sight-threatening eye infection, mostly in contact lens wearers. Although infections due to pathogenic amoebae are considered rare, recently, these deadly amoebae were detected in water supplies in the USA. This is of particular concern, especially with global warming further exacerbating the problem. Herein, we describe the epidemiology, presentation, diagnosis, and management of free-living amoeba infections.

Entities:  

Keywords:  Balamuthia; CNS infection; Free-living amoebae; Naegleria; acanthamoeba; encephalitis; keratitis; meningoencephalitis

Mesh:

Year:  2021        PMID: 34602025      PMCID: PMC8933017          DOI: 10.1080/20477724.2021.1985892

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   3.735


  169 in total

1.  Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection.

Authors:  Francisco G Bravo; Carlos Seas
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

3.  HMG-CoA Reductase Inhibitors as Drug Leads against Naegleria fowleri.

Authors:  Hye Jee Hahn; Ruben Abagyan; Larissa M Podust; Shantanu Roy; Ibne Karim M Ali; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-09-19       Impact factor: 4.418

4.  The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates.

Authors:  T Mazur; E Hadaś; I Iwanicka
Journal:  Trop Med Parasitol       Date:  1995-06

Review 5.  Infections with free-living amebae.

Authors:  Govinda S Visvesvara
Journal:  Handb Clin Neurol       Date:  2013

6.  Occurrence of free-living amoebae (Acanthamoeba, Balamuthia, Naegleria) in water samples in Peninsular Malaysia.

Authors:  Shobana Gabriel; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  J Water Health       Date:  2019-02       Impact factor: 1.744

7.  A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient.

Authors:  R Walia; J G Montoya; G S Visvesvera; G C Booton; R L Doyle
Journal:  Transpl Infect Dis       Date:  2007-03       Impact factor: 2.228

8.  Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Authors:  Jong-Hyun Kim; Suk-Yul Jung; Yang-Jin Lee; Kyoung-Ju Song; Daeho Kwon; Kyongmin Kim; Sun Park; Kyung-Il Im; Ho-Joon Shin
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

Review 9.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more
  3 in total

1.  Novel Plant-Based Metabolites as Disinfectants against Acanthamoeba castellanii.

Authors:  Ruqaiyyah Siddiqui; Noor Akbar; Bushra Khatoon; Muhammad Kawish; Muhammad Shaiq Ali; Muhammad Raza Shah; Naveed Ahmed Khan
Journal:  Antibiotics (Basel)       Date:  2022-02-14

2.  Copper Metabolism in Naegleria gruberi and Its Deadly Relative Naegleria fowleri.

Authors:  Kateřina Ženíšková; Maria Grechnikova; Robert Sutak
Journal:  Front Cell Dev Biol       Date:  2022-04-11

3.  Homology Modeling, Molecular Docking, Molecular Dynamic Simulation, and Drug-Likeness of the Modified Alpha-Mangostin against the β-Tubulin Protein of Acanthamoeba Keratitis.

Authors:  Tassanee Ongtanasup; Anisha Mazumder; Anupma Dwivedi; Komgrit Eawsakul
Journal:  Molecules       Date:  2022-09-26       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.